Clasp Therapeutics Revenue

Biotechnology Research • United States • 21-50 Employees

Clasp Therapeutics revenue & valuation

Annual revenue	$4,021,085
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$12,900,000
Total funding	$150,000,000

Key Contacts at Clasp Therapeutics

Julia Shepherd

Senior Director, Clinical Operations

Robert Ross

Chief Executive Officer

James Bingham

Chief Technology Officer

Mike Maloney

Director, Biology

Zack Derboghosian

Director, Finance

Jennifer Mancuso

Director Of It

Stuart Underwood

Director Process Development

Jessica Kohler

Director, Immunology

Company overview

Headquarters	United States
Website	clasptx.com
NAICS	541714
Founded	2020
Employees	21-50
Socials

Clasp Therapeutics Email Formats

Clasp Therapeutics uses 5 email formats. The most common is {first initial}{last name} (e.g., jdoe@clasptx.com), used 55.3% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@clasptx.com	55.3%
{first name}{last name}	johndoe@clasptx.com	26.3%
{first initial}	j@clasptx.com	7.9%
{first name}	john@clasptx.com	7.9%
{last name}{last name}	doedoe@clasptx.com	2.6%

About Clasp Therapeutics

Clasp Therapeutics aims to bring absolute precision to immuno-oncology by developing next-generation T cell engagers (TCEs) that target tumor-specific oncogenic driver mutations across hard-to-treat cancers. Clasp is developing T cell engagers to match both the specific characteristics of the patient’s immune system and the specific genetics of their tumor, enabling the creation of exquisitely personalized, yet off-the-shelf, therapeutics. Built upon academic research in the labs of Bert Vogelstein and Drew Pardoll at Johns Hopkins University, Clasp is backed by prominent life sciences investors including Catalio Capital Management, Third Rock Ventures and Novo Holdings. The company was launched in March 2024 and is based in Cambridge, MA and Rockville, MD. For more information about Clasp, please visit www.clasptx.com

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry

Senior

Director

Employees by Department

Clasp Therapeutics has 11 employees across 8 departments.

Departments

Number of employees

Funding Data

Explore Clasp Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2024-04-20	4	$150,000,000

Funding Insights

$150,000,000

Total funding amount

$150,000,000

Most recent funding amount

Number of funding rounds

Clasp Therapeutics Tech Stack

Discover the technologies and tools that power Clasp Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Modernizr

JavaScript libraries

jQuery CDN

CDN

reCAPTCHA

Security

Microsoft 365

Cloudflare

CDN

jQuery

JavaScript libraries

Stimulus

JavaScript frameworks

HSTS

Security

Google Analytics

Analytics

Emotion

Development

Squarespace Commerce

Ecommerce

Google Tag Manager

Tag managers

Frequently asked questions

Clasp Therapeutics is located in US.

Clasp Therapeutics generates an estimated annual revenue of $4,021,085. This revenue figure reflects the company's market position and business performance in its industry.

Clasp Therapeutics has an estimated valuation of $12,900,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Clasp Therapeutics was founded in 2020, making it 6 years old. The company has established itself as a significant player in its industry over this time.

Clasp Therapeutics has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

Clasp Therapeutics has raised a total of $150,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.